← Who reports today · Health Care
BSX earnings date & Q2 2026 results · Boston Scientific
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 07/29/2026
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. · Text: Wikipedia, CC BY-SA 4.0, abridged
Key growth driver: Revenue growth of +8% y/y — the report gives no segment split, so the driver is the whole business. · by the Q2 2026 report
When is BSX’s next earnings date?
Wednesday, October 21, 2026estimated
Expected around Oct 21 — based on last year’s report on Oct 22, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once BSX announces it.
Same quarter a year ago (ended September 30, 2025): revenue $5.07B, EPS (GAAP) $0.51
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does BSX report? Usually before market open: the last 4 results releases reached the SEC at 6:33 am, 6:34 am, 6:33 am, 6:32 am ET.
Last report: Jul 29, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$5,442
+7.5%
Gross profit
$3,848
+12.4%
70.7% margin
Operating income
$1,178
+43.8%
21.6% margin
Net income
$907
+13.8%
$0.61/sh · 16.7% margin
Verdict: revenue grew 7.5% y/y to $5.44B, operating margin 21.6% vs 16.2%, net income $907M (+13.8% y/y).
Source and notation
Source: Boston Scientific press release, 8-K EX-99.1 of 07/29/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
BSX earnings history: past report dates
| Jul 29, 2026 Wed | 6:33 ambefore market open | Jun 30, 2026 | $5.4B+8% y/y | $0.61+15% y/y |
| Apr 22, 2026 Wed | 6:34 ambefore market open | Mar 31, 2026 | $5.2B+12% y/y | $0.90+100% y/y |
| Feb 4, 2026 Wed | 6:33 ambefore market open | Dec 31, 2025 | ≈$5.3B+16% y/y | ≈$0.45+18% y/y |
| Oct 22, 2025 Wed | 6:32 ambefore market open | Sep 30, 2025 | $5.1B+20% y/y | $0.51+59% y/y |
| Jul 23, 2025 Wed | 6:32 ambefore market open | Jun 30, 2025 | $5.1B+23% y/y | $0.53+141% y/y |
| Apr 23, 2025 Wed | 6:34 ambefore market open | Mar 31, 2025 | $4.7B+21% y/y | $0.45+36% y/y |
| Feb 5, 2025 Wed | 6:41 ambefore market open | Dec 31, 2024 | ≈$4.6B+22% y/y | ≈$0.38+12% y/y |
| Oct 23, 2024 Wed | 6:32 ambefore market open | Sep 30, 2024 | $4.2B+19% y/y | $0.32−6% y/y |
| Jul 24, 2024 Wed | 6:35 ambefore market open | Jun 30, 2024 | $4.1B+14% y/y | $0.22+22% y/y |
| Apr 24, 2024 Wed | 6:34 ambefore market open | Mar 31, 2024 | $3.9B+14% y/y | $0.33+57% y/y |
| Jan 31, 2024 Wed | 6:32 ambefore market open | Dec 31, 2023 | ≈$3.7B+15% y/y | ≈$0.34+278% y/y |
| Oct 26, 2023 Thu | 6:36 ambefore market open | Sep 30, 2023 | $3.5B+11% y/y | $0.34+183% y/y |
| Jul 27, 2023 Thu | 6:43 ambefore market open | Jun 30, 2023 | $3.6B+11% y/y | $0.18+6% y/y |
| Apr 26, 2023 Wed | 6:34 ambefore market open | Mar 31, 2023 | $3.4B+12% y/y | $0.21+200% y/y |
| Feb 1, 2023 Wed | 6:34 ambefore market open | Dec 31, 2022 | ≈$3.2B+4% y/y | ≈$0.09+50% y/y |
| Oct 26, 2022 Wed | 6:38 ambefore market open | Sep 30, 2022 | $3.2B+8% y/y | $0.12−57% y/y |
Show all 16 reports since 2022Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Boston Scientific: 15-year financials
| 2025 | 20,074 | 3,613 | 2,898 | 3,658 | — |
| 2024 | 16,747 | 2,603 | 1,853 | 2,645 | — |
| 2023 | 14,240 | 2,343 | 1,570 | 1,792 | 28 |
| 2022 | 12,682 | 1,649 | 642 | 938 | 55 |
| 2021 | 11,888 | 1,199 | 985 | 1,316 | 55 |
| 2020 | 9,913 | −80 | −115 | 1,132 | 28 |
| 2019 | 10,735 | 1,518 | 4,700 | 1,375 | — |
| 2018 | 9,823 | 1,506 | 1,671 | −6 | — |
| 2017 | 9,048 | 1,285 | 104 | 1,107 | — |
| 2016 | 8,386 | 447 | 347 | 806 | — |
| 2015 | 7,477 | −283 | −239 | 444 | — |
| 2014 | 7,462 | −301 | −119 | 1,010 | — |
| 2013 | 7,072 | 120 | −121 | 865 | — |
| 2012 | 7,249 | −3,868 | −4,068 | 1,054 | — |
| 2011 | 7,622 | 904 | 441 | 704 | — |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $24.9B (55% of total assets). Compare with other S&P 500 companies →
Included in screener lists: Piotroski F-score: S&P 500 companies scoring 8 or 9
Boston Scientific (BSX) earnings: FAQ
When is BSX's next earnings date?
We have not yet seen an announcement of the date from Boston Scientific (BSX). Based on last year's report on Oct 22, 2025, the next report is expected around Oct 21, 2026.
What time does BSX report earnings?
Boston Scientific usually reports before market open: its latest results release was filed with the SEC at 6:33 am ET on Jul 29, 2026.
When did BSX last report earnings?
Boston Scientific reported Q2 2026 results on Jul 29, 2026.
Where can I find Boston Scientific's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to BSX's filings; this page breaks the latest report down in a Sankey chart.
What was BSX's net income in Q2 2026?
Boston Scientific reported net income of $907M for Q2 2026 (+13.8% year over year), under US GAAP.
How has Boston Scientific's revenue changed since 2011?
Per its 10-K filings, revenue grew 2.6x: $7,622M in 2011 and $20,074M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: CAH · Q4 FY2026 · CI · Q2 2026 · CNC · Q2 2026 · CVS · Q2 2026 · DGX · Q2 2026 · DHR · Q2 2026 · DVA · Q2 2026 · DXCM · Q2 2026 · ELV · Q2 2026 · EW · Q2 2026 · all reports